All In Biotech

Drug Trial Radar · NCT05322616

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Assess the Safety and Tolerability of JK07 in Subjects With Heart Failure With Preserved Ejection Fraction (HFpEF)

Last checked: Nov 19, 2026Latest source record: May 31, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Oct 21, 2022

Primary completion

May 26, 2023

Study completion May 26, 2023

Sponsor

Lead sponsor
Salubris Biotherapeutics IncIndustry
Sponsor type
Industry
First posted
Apr 12, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 1, randomized, double-blind, placebo-controlled single-ascending dose study to assess JK07 in adult subjects with heart failure with preserved ejection fraction.

Conditions

  • Heart Failure With Preserved Ejection Fraction

Interventions

  • JK07Drug

    Recombinant fusion protein consisting of a fully humanized immunoglobulin G1 monoclonal antibody and an active polypeptide fragment of the human growth factor NRG-1

  • Matching PlaceboDrug

    Vehicle control

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety AssessmentTime frame: Screening to Day 28

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University Medical Center

    Stanford, California

  • Harvard Medical School/Massachusetts General Hospital

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University

    St Louis, Missouri

  • Cleveland Clinic

    Cleveland, Ohio

  • Oregon Health and Science University Hospital

    Portland, Oregon

  • Houston Methodist Hospital

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.